St Jude Childrens Research Hospital Inc
Public records show a registered, tax-exempt organization in good standing.
What it says it does
THE MISSION OF ST. JUDE CHILDREN'S RESEARCH HOSPITAL IS TO ADVANCE CURES, AND MEANS OF PREVENTION, FOR PEDIATRIC CATASTROPHIC DISEASES THROUGH RESEARCH AND TREATMENT. CONSISTENT WITH THE VISION OF OUR FOUNDER DANNY THOMAS, NO CHILD IS DENIED (CONTINUED ON SCHEDULE O) TREATMENT BASED ON RACE, RELIGION OR A FAMILY'S ABILITY TO PAY.
- Income
- $2.2 billion
- Spending
- $1.9 billion
- Spent on programs
- 93%
- Reserves
- 58.5 months of spending
- Largest source of income
- donations and private grants, 86%
- Employees
- 7,862
- Volunteers
- 431
- Highest pay
- $1.7 million, president/ceo
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Strong: 100 out of 100. Higher than 96% of charities in its peer group (health care, over $100m).
Reserves
35 of 35Spendable reserves would cover 58.5 months of spending.
Debt
20 of 20It owes 3% of what it owns.
Living within its means
15 of 15Income exceeded spending by 14% of income.
Income trend
15 of 15Income rose 10% on the year before.
Spending floor
15 of 1593% of spending went to programs and raising each dollar of donations cost 0 cents.
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Strong: 100 out of 100. Higher than 53% of charities in its peer group (health care, over $100m).
Independent board
25 of 2535 of 37 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
8 of 8Has a written whistleblower policy.
Record keeping policy
7 of 7Has a written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
10 of 10Gave the board a copy of this return before filing it.
Pay set independently
5 of 5Sets its chief executive's pay through independent review and comparison.
Independent check of accounts
15 of 15Its accounts were audited by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (3)
- $883.2 million spent. RESEARCH: THE CURRENT BASIC SCIENCE AND CLINICAL RESEARCH AT THE HOSPITAL INCLUDES WORK IN GENE THERAPY, CHEMOTHERAPY, THE BIOCHEMISTRY OF NORMAL AND CANCEROUS CELLS, RADIATION TREATMENT, BLOOD DISEASES, RESISTANCE TO THERAPY, VIRUSES, NEUROLOGICAL DISEASES, HEREDITARY DISEASES, INFLUENZA, PEDIATRIC AIDS AND PHYSIOLOGICAL EFFECTS OF CATASTROPHIC ILLNESSES.
- $726.7 million spent. PATIENT CARE: THE HOSPITAL PROVIDED 17,927 INPATIENT DAYS OF CARE DURING THE YEAR. OUR BONE MARROW TRANSPLANTATION PROGRAM ACCOUNTED FOR 3,805 OR 21% OF THOSE INPATIENT DAYS. PATIENTS MADE 74,651 CLINIC REGISTRATIONS DURING THE YEAR.
- $146.2 million spent. EDUCATION AND TRAINING: AS PART OF ITS MISSION, THE INSTITUTION HAS DEVELOPED A GLOBAL INITIATIVE (ST. JUDE GLOBAL) TO IMPROVE THE SURVIVAL RATES OF CHILDREN WITH CANCER AND OTHER CATASTROPHIC DISEASES WORLDWIDE. ST. JUDE GLOBAL ACCOMPLISHES THIS BY SHARING KNOWLEDGE, TECHNOLOGY AND ORGANIZATIONAL SKILLS, HELPING TO IMPLEMENT NEW APPROACHES TO TREAT PEDIATRIC CANCER GLOBALLY, AND DEVELOPING REGIONAL NETWORKS COMMITTED TO ERADICATING CANCER IN CHILDREN. THIS MISSION WILL BE ACHIEVED BY FOCUSING ON THREE OVERRIDING GOALS: (1) TO TRAIN THE CLINICAL WORKFORCE THAT WILL BE REQUIRED TO MEET OUR MISSION, (2) TO DEVELOP AND STRENGTHEN HEALTH SYSTEMS AND PATIENT-CENTERED INITIATIVES THAT ENCOMPASS THE ENTIRE CONTINUUM OF CARE REQUIRED FOR CHILDREN WITH CANCER AND NON-MALIGNANT HEMATOLOGICAL (CONTINUED ON SCHEDULE O) DISEASES, AND (3) TO ADVANCE KNOWLEDGE IN GLOBAL PEDIATRIC ONCOLOGY AND HEMATOLOGY THROUGH RESEARCH TO SUSTAIN A CONTINUOUS IMPROVEMENT IN THE LEVEL AND QUALITY OF CARE DELIVERED AROUND THE GLOBE. THESE INITIATIVES ARE SPEARHEADED BY ST. JUDE EXPERTS WHO WORK CLOSELY WITH HEALTHCARE PROFESSIONALS AT OUR PARTNER SITES.THE GLOBAL INITIATIVE FOR CHILDHOOD CANCER, LAUNCHED IN 2018 BY ST. JUDE IN PARTNERSHIP WITH WHO AND GLOBAL COLLABORATORS, AIMS TO ADDRESS DISPARITIES IN CHILDHOOD CANCER OUTCOMESWHERE SURVIVAL IS BELOW 30% IN MANY LOW AND MIDDLE INCOME COUNTRIES COMPARED TO OVER 80% IN HIGH INCOME SETTINGS. THE INITIATIVE SEEKS TO RAISE GLOBAL SURVIVAL TO AT LEAST 60% BY 2030 BY STRENGTHENING COUNTRIES' ABILITY TO DELIVER QUALITY CANCER CARE AND ELEVATING CHILDHOOD CANCER AS A NATIONAL AND INTERNATIONAL HEALTH PRIORITY. STAKEHOLDERS ACROSS SECTORS ARE WORKING TOGETHER TO IMPROVE ACCESS, CAPACITY, AND COORDINATED ACTION FOR CHILDREN WITH CANCER WORLDWIDE.THE GLOBAL PLATFORM FOR ACCESS TO CHILDHOOD CANCER MEDICINES IS A MAJOR EFFORT LED BY ST. JUDE TO ENSURE LIFESAVING CANCER TREATMENTS ARE AVAILABLE, ACCESSIBLE, AFFORDABLE, AND HIGH QUALITY FOR CHILDREN WORLDWIDE. BACKED BY A $200 MILLION ST. JUDE INVESTMENT AND BUILT IN PARTNERSHIP WITH WHO, UNICEF, AND PAHO, THE INITIATIVE IS RESTRUCTURING THE FRAGMENTED PEDIATRIC CANCER MEDICINE MARKET TO HELP ACHIEVE GLOBAL SURVIVAL GOALS. PILOT DELIVERIES BEGAN IN 2025, WITH ADDITIONAL COUNTRIES NOW ONBOARDING AS THE PROGRAM SCALES TOWARD REACHING 120,000 CHILDREN WITHIN THE NEXT SEVEN YEARS.GRADUATE PROGRAMS AT BOTH THE MASTER'S AND DOCTORAL LEVELS ARE OFFERED THROUGH A WHOLLY OWNED SUBSIDIARY, ST. JUDE CHILDREN'S RESEARCH HOSPITAL GRADUATE SCHOOL OF BIOMEDICAL SCIENCES, LLC, TO EDUCATE THE NEXT GENERATION OF BIOMEDICAL RESEARCHERS TO PROBE THE MOLECULAR BASIS OF DISEASE, DEVELOP NOVEL THERAPIES AND TRAIN MEDICAL PROFESSIONALS TO ADVANCE GLOBAL HEALTH FOR CHILDREN WITH CATASTROPHIC DISEASES.
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated September 30, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated September 10, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending June 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since May 1963.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated September 7, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 7, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.